165 related articles for article (PubMed ID: 16455660)
1. Parkin suppresses the expression of monoamine oxidases.
Jiang H; Jiang Q; Liu W; Feng J
J Biol Chem; 2006 Mar; 281(13):8591-9. PubMed ID: 16455660
[TBL] [Abstract][Full Text] [Related]
2. Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases.
Ren Y; Jiang H; Ma D; Nakaso K; Feng J
Hum Mol Genet; 2011 Mar; 20(6):1074-83. PubMed ID: 21177257
[TBL] [Abstract][Full Text] [Related]
3. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.
Jiang H; Ren Y; Yuen EY; Zhong P; Ghaedi M; Hu Z; Azabdaftari G; Nakaso K; Yan Z; Feng J
Nat Commun; 2012 Feb; 3():668. PubMed ID: 22314364
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.
Ugun-Klusek A; Theodosi TS; Fitzgerald JC; Burté F; Ufer C; Boocock DJ; Yu-Wai-Man P; Bedford L; Billett EE
Redox Biol; 2019 Jan; 20():167-181. PubMed ID: 30336354
[TBL] [Abstract][Full Text] [Related]
5. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
6. Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.
Jiang H; Jiang Q; Feng J
J Biol Chem; 2004 Dec; 279(52):54380-6. PubMed ID: 15492001
[TBL] [Abstract][Full Text] [Related]
7. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
Klegeris A; McGeer PL
Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins.
Fitzgerald JC; Ugun-Klusek A; Allen G; De Girolamo LA; Hargreaves I; Ufer C; Abramov AY; Billett EE
FASEB J; 2014 Jan; 28(1):218-29. PubMed ID: 24051032
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.
Fitzgerald JC; Ufer C; De Girolamo LA; Kuhn H; Billett EE
J Neurochem; 2007 Dec; 103(6):2189-99. PubMed ID: 17883400
[TBL] [Abstract][Full Text] [Related]
10. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
Naoi M; Maruyama W; Akao Y; Yi H; Yamaoka Y
J Neural Transm Suppl; 2006; (71):67-77. PubMed ID: 17447417
[TBL] [Abstract][Full Text] [Related]
11. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1.
Roth JA; Singleton S; Feng J; Garrick M; Paradkar PN
J Neurochem; 2010 Apr; 113(2):454-64. PubMed ID: 20089134
[TBL] [Abstract][Full Text] [Related]
12. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
[TBL] [Abstract][Full Text] [Related]
13. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
14. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
Ren Y; Zhao J; Feng J
J Neurosci; 2003 Apr; 23(8):3316-24. PubMed ID: 12716939
[TBL] [Abstract][Full Text] [Related]
15. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
[TBL] [Abstract][Full Text] [Related]
16. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.
Rothfuss O; Fischer H; Hasegawa T; Maisel M; Leitner P; Miesel F; Sharma M; Bornemann A; Berg D; Gasser T; Patenge N
Hum Mol Genet; 2009 Oct; 18(20):3832-50. PubMed ID: 19617636
[TBL] [Abstract][Full Text] [Related]
17. Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation.
Ren Y; Jiang H; Yang F; Nakaso K; Feng J
J Biol Chem; 2009 Feb; 284(6):4009-17. PubMed ID: 19074146
[TBL] [Abstract][Full Text] [Related]
18. Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.
Wayment HK; Schenk JO; Sorg BA
J Neurosci; 2001 Jan; 21(1):35-44. PubMed ID: 11150317
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of brain MAO-A and animal behaviour induced by p-hydroxyamphetamine.
Arai Y; Kim SK; Kinemuchi H; Tadano T; Oyama K; Satoh N; Kisara K
Brain Res Bull; 1991 Jul; 27(1):81-4. PubMed ID: 1933439
[TBL] [Abstract][Full Text] [Related]
20. Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin.
Siddiqui A; Hanson I; Andersen JK
Free Radic Res; 2012 Aug; 46(8):1011-8. PubMed ID: 22329629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
